Results 181 to 190 of about 1,062,704 (335)

Introduction to the Experiment of Genetic Engineering. X. protein engineering

, 1988
Hiroyuki Adachi, Hiroshi Matsuzawa
openalex   +2 more sources

Genetic Engineering and Genetics Education

The American Biology Teacher, 1978
openaire   +2 more sources

A DIA‐MS‐based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients

Molecular Oncology, EarlyView.
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul, François Guillonneau, Odile Blanchet, Hamza Lasla, Audrey Rousseau, Catherine Guette, Alice Boissard, Cécile Henry, Morgan Dhondt, Pascal Jézéquel, Philippe Menei, Jean‐Michel Lemée   +11 more
wiley   +1 more source

Knowledge, Attitudes, and Acceptance of Genetic Engineering Among Adults in the UAE: A Cross-Sectional Study. [PDF]

Cureus
Masoud AE, Mesmar HA, Omair M, Alkaabi NM, Alqaydi MM, Dafalla MA, Ebby S, Hussein A.   +7 more
europepmc   +1 more source

Introduction to the Experiments of Genetic Engineering. III. Gene library (Microorganism)

, 1987
Masatoshi Takagi
openalex   +2 more sources

Transposons and Integrons: Natural Genetic Engineering of Bacterial Resistance [PDF]

, 1999
Paul H. Roy
openalex   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source

Evaluation and modification of tumor cell isolation techniques from malignant effusions for rapid drug sensitivity testing

Molecular Oncology, EarlyView.
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef, Hana Barhom, Sumit Chatterji, Netta Hecht, Oran Warhaftig, Iris Kamer, Oranit Zadok, Jair Bar, Limor Broday, Amir Onn, Michael Peled   +10 more
wiley   +1 more source

Use of the genetic engineering growth hormone SAISEN in children with somatotropic insufficiency: Results of clinical trials in Russia

, 1994
И. И. Дедов, Valentina Peterkova, Н. П. Гончаров, T. I. Buraya, О. В. Фофанова, С. С. Панкова, А И Бухман   +6 more
openalex   +1 more source

Genetic Engineering in Tissue Culture of Medicinal Plants.

, 1993
Kazuki Saito
openalex   +1 more source